These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15850051)

  • 1. [Role of some representatives of opportunistic microflora in development of secondary infection in patients with pulmonary tuberculosis].
    Ivushkina LV; Mitrokhin SD; Moroz AM
    Antibiot Khimioter; 2004; 49(10):7-9. PubMed ID: 15850051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gramnegative opportunistic microflora as etiological factor of secondary infection in patients with pulmonary tuberculosis].
    Ivushkina LV; Mitrokhin SD; Mironov AIu
    Antibiot Khimioter; 2006; 51(1):11-3. PubMed ID: 16734359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rational antimicrobial pharmacotherapy of secondary infections in patients with pulmonary tuberculosis].
    Mitrokhin SD; Ivushkina LV; Mironov AIu
    Antibiot Khimioter; 2005; 50(7):32-6. PubMed ID: 16768212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mef(A), mef(E) and a new mef allele in macrolide-resistant Streptococcus spp. isolates from Norway.
    Sangvik M; Littauer P; Simonsen GS; Sundsfjord A; Dahl KH
    J Antimicrob Chemother; 2005 Nov; 56(5):841-6. PubMed ID: 16172106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Classical and new approaches in laboratory diagnosis of viridans streptococci].
    Ergin A
    Mikrobiyol Bul; 2010 Jul; 44(3):495-503. PubMed ID: 21064001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Respiratory tract mycotic infection in phthisiological practice: species composition and susceptibility of the Candida clinical isolates to antifungal agents].
    Kul'ko AB; Mitrokhin SD; Moroz AM
    Antibiot Khimioter; 2005; 50(4):14-7. PubMed ID: 16392334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viridans streptococci isolated by culture from blood of cancer patients: clinical and microbiologic analysis of 50 cases.
    Han XY; Kamana M; Rolston KV
    J Clin Microbiol; 2006 Jan; 44(1):160-5. PubMed ID: 16390964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of antibiotic susceptibility in viridans group streptococci in low and high antibiotic-prescribing General Practices.
    Goldsmith CE; Hara Y; Sato T; Nakajima T; Nakanishi S; Mason C; Moore JE; Matsuda M; Coulter WA
    J Clin Pharm Ther; 2015 Apr; 40(2):204-7. PubMed ID: 25604860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penicillin G-resistant viridans group streptococcal endocarditis and interpretation of the American Heart Association's Guidelines for the Treatment of Infective Endocarditis.
    Fujitani S; Rowlinson MC; George WL
    Clin Infect Dis; 2008 Apr; 46(7):1064-6. PubMed ID: 18444825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic sensitivities of Streptococcus pneumoniae, viridans streptococci, and group A hemolytic streptococci isolated from the maxillary and ethmoid sinuses.
    Keleş E; Aral M; Alpay HC
    Kulak Burun Bogaz Ihtis Derg; 2006; 16(1):18-24. PubMed ID: 16763410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
    Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
    J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective national survey of viridans streptococcal bacteraemia risk factors, antibacterial susceptibility and outcome of 120 episodes.
    Mrazova M; Docze A; Buckova E; Bucko L; Kacmarikova M; Grey E; Korcova J; Koprnova J; Saboova Z; Beno P; Karvaj M; Svetlansky I; Ondrus A; Benca J; Taziarova M; Rudinsky B; Krcmery V
    Scand J Infect Dis; 2005; 37(9):637-41. PubMed ID: 16126562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization and phylogenetic analysis of quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC and parE gene loci in viridans group streptococci isolated from adult patients with cystic fibrosis.
    Maeda Y; Murayama M; Goldsmith CE; Coulter WA; Mason C; Millar BC; Dooley JS; Lowery CJ; Matsuda M; Rendall JC; Elborn JS; Moore JE
    J Antimicrob Chemother; 2011 Mar; 66(3):476-86. PubMed ID: 21193474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with formalin-inactivated influenza vaccine protects mice against lethal influenza Streptococcus pyogenes superinfection.
    Okamoto S; Kawabata S; Fujitaka H; Uehira T; Okuno Y; Hamada S
    Vaccine; 2004 Jul; 22(21-22):2887-93. PubMed ID: 15246625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-resistant viridans streptococcal pneumonia and sepsis in the ventilated newborn.
    Günlemez A; Atasay B; Güriz H; Aysev D; Arsan S
    Ann Trop Paediatr; 2004 Sep; 24(3):253-8. PubMed ID: 15479576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic synergy against viridans streptococci isolated in infective endocarditis.
    Sunnerhagen T; Nilson B; Rasmussen M
    Int J Antimicrob Agents; 2015 May; 45(5):550-1. PubMed ID: 25697413
    [No Abstract]   [Full Text] [Related]  

  • 17. [Problems with identification of beta-hemolytic streptococcus resistant to bacitracin isolated from patients with pharyngitis].
    Olender A; Łetowska I; Karyński M; Kiernicka-Ciekot K; Pels K
    Med Dosw Mikrobiol; 2012; 64(1):1-10. PubMed ID: 22808724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of viridans group streptococci isolated from dento-alveolar infections to eight antimicrobial agents.
    Smith AJ; Jackson MS
    J Antimicrob Chemother; 2003 Dec; 52(6):1045-6. PubMed ID: 14613956
    [No Abstract]   [Full Text] [Related]  

  • 19. Nosocomial bloodstream infections due to viridans streptococci in haematological and non-haematological patients: species distribution and antimicrobial resistance.
    Lyytikäinen O; Rautio M; Carlson P; Anttila VJ; Vuento R; Sarkkinen H; Kostiala A; Väisänen ML; Kanervo A; Ruutu P
    J Antimicrob Chemother; 2004 Apr; 53(4):631-4. PubMed ID: 15014065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF).
    Maeda Y; Elborn JS; Parkins MD; Reihill J; Goldsmith CE; Coulter WA; Mason C; Millar BC; Dooley JS; Lowery CJ; Ennis M; Rendall JC; Moore JE
    J Cyst Fibros; 2011 Mar; 10(2):133-9. PubMed ID: 21145793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.